Home › Funds › Eiger Wealth Management, LLC › FATE

Eiger Wealth Management, LLC position in FATE

Fate Therapeutics Inc · Health Care

Eiger Wealth Management, LLC reported holding 10,000 shares of FATE (Fate Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$24K, representing 0.51% of its reported portfolio and ranking #17 among its reported holdings. Eiger Wealth Management, LLC has disclosed FATE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)10.00K sh
Reported value held$23.70K
Portfolio Weight0.51%
First reportedQ4 2025
Last changeHold
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How Eiger Wealth Management, LLC's FATE position evolved

Eiger Wealth Management, LLC first disclosed a stake in FATE in Q4 2025 at 10,000 shares (US$10K). The position peaked in Q2 2026 at 10,000 shares, worth US$27K. Across 4 filings, Eiger Wealth Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 10,000 shares valued at US$24K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.00K $9.83K New
Q1 2026 10.00K $12.00K Hold
Q2 2026 10.00K $27.00K Hold
Q3 2026 10.00K $23.70K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FATE and 13F data

FATE (Fate Therapeutics Inc) is a Health Care company. 19 other funds we track also report a position in FATE — the largest reported positions include Redmile Group, LLC (US$34.8M), JOHNSON & JOHNSON (US$9.1M), Bruce & Co., Inc. (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FATE

All FATE fund holders →

FAQ

How long has Eiger Wealth Management, LLC held FATE?

Eiger Wealth Management, LLC has disclosed FATE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Eiger Wealth Management, LLC's current position in FATE?

As of Q3 2026, Eiger Wealth Management, LLC holds 10.00K shares of FATE (Fate Therapeutics Inc), valued at $23.70K, representing 0.51% of its reported portfolio and ranking #17.

Has Eiger Wealth Management, LLC been buying or selling FATE?

In the latest 13F filing (Q3 2026), Eiger Wealth Management, LLC held unchanged its position in FATE. The position peaked in Q2 2026 at 10.00K shares.

Which other funds hold FATE?

Other major institutional holders of FATE include Redmile Group, LLC, JOHNSON & JOHNSON, Bruce & Co., Inc., among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.